Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Marraffino, Andrea
KP415P01, NCT05685732: An Efficacy and Safety Study w/ Azstarys® in Children With ADHD	Active, not recruiting	4	246	US	Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), placebo	Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac	Attention Deficit/Hyperactivity Disorder	05/24	06/24
KP415P02, NCT05721235: A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD	Recruiting	4	100	US	Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)	Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac, Worldwide Clinical Trials	Attention Deficit/Hyperactivity Disorder	03/25	03/25
ADHD, NCT06215144: Study to Evaluate NRCT-101SR in Pediatric Subjects With	Recruiting	2/3	160	US	NRCT-101SR, Matching Placebo	Neurocentria, Inc.	Attention-Deficit/Hyperactivity Disorder (ADHD)	12/24	02/25